Article

DNA vaccine protection against SARS-CoV-2 in rhesus macaques

2020-10-13

Abstract excerpt

The global coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has made the development of a vaccine a top biomedical priority. In this study, we developed a series of DNA vaccine candidates expressing different forms of the SARS-CoV-2 spike (S) protein and evaluated them in 35 rhesus macaques. Vaccinated animals developed humoral and cellular immune...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 1f8c0e84-a78a-5774-8913-772c03266c55
DOI: 10.17615/7ywj-4d04

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

DNA vaccine protection against SARS-CoV-2 in rhesus macaquesDOI 10.17615/7ywj-4d04Read

A novel DNA and protein combination COVID-19 vaccine formulation provides full protection against SARS-CoV-2 in rhesus macaquesSemantic proximity Read

A self-amplifying mRNA COVID-19 vaccine drives potent and broad immune responses at low doses that protects non-human primates against SARS-CoV-2Semantic proximity Read

Protein Vaccine Induces a Durable, More Broadly Neutralizing Antibody Response in Macaques than Natural Infection with SARS-CoV-2 P.1Semantic proximity Read

A Capsid Virus-Like Particle-Based SARS-CoV-2 Vaccine Induces High Levels of Antibodies and Protects Rhesus MacaquesSemantic proximity Read

Preclinical evaluation of a candidate naked plasmid DNA vaccine against SARS-CoV-2Semantic proximity Read

An adenovirus-vectored COVID-19 vaccine confers protection from SARS-COV-2 challenge in rhesus macaquesSemantic proximity Read

A synthetic peptide CTL vaccine targeting nucleocapsid confers protection from SARS-CoV-2 challenge in rhesus macaquesSemantic proximity Read

SARS-CoV-2 preS dTM vaccine booster candidates increase functional antibody responses and cross-neutralization against SARS-CoV-2 variants of concern in non-human primatesSemantic proximity Read

Boosting of SARS-CoV-2 immunity in nonhuman primates using an oral rhabdoviral vaccineSemantic proximity Read

Single-dose AAV-based vaccine induces a high level of neutralizing antibodies against SARS-CoV-2 in rhesus macaquesSemantic proximity Read

Dynamics of Temporal Immune Responses in Nonhuman Primates and Humans Immunized with COVID-19 VaccinesSemantic proximity Read

Assessment of the efficacy of SARS-CoV-2 vaccines in non-human primate studies: a systematic reviewSemantic proximity Read